Polycyclic aromatic hydrocarbons enhance terminal cell death of human ectocervical cells

International Journal of Oncology

Volumn 13, Issue 3, 1998, Pages 557-563

  Rorke, Ellen A ^a,c   Sizemore, Nywana ^a   Mukhtar, Hasan ^a   Couch, Letha H ^b   Howard, Paul C ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

3 methylcholanthrene; 32P postlabeling; Ectocervical cells; Human papilloma virus; Immortalization; P53

Indexed keywords

3 METHYLCHOLANTHRENE; BENZO[A]PYRENE; BENZ[A]ANTHRACENE; CARCINOGEN; DNA; INVOLUCRIN; KERATIN; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P53; XENOBIOTIC AGENT;

ARTICLE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE; PAPILLOMA VIRUS; PRIORITY JOURNAL; UTERINE CERVIX; XENOBIOTIC METABOLISM;

EID: 0031829628     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.3.557     Document Type: Article

References (61)

1. Zur Hausen H: Papillomaviruses in human cancers. Mol Carcinogen 1: 147-150, 1988.
2. Brinton LA and Fraumeni JFJ: Epidemiology of uterine cervical cancer. J Chronic Dis 39: 1051-1065, 1986.
3. Agarwal C, Rorke EA, Irwin JC and Eckert RL: Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res 51: 3982-3989, 1991.
4. Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR and Schiller JT: The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J Virol 65: 4860-4866, 1991.
5. Wolterbeek AP, Schoevers EJ, Rutten AA and Feron VJ: A critical appraisal of intratracheal instillation of benzo[a]pyrene to Syrian golden hamsters as a model in respiratory tract carcinogenesis. Cancer Lett 89: 107-116, 1995.
6. Yuspa SH: The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. Thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 54: 1178-1189, 1994.
7. Fortini P and Dogliotti E: Molecular analysis of mutations induced by chemical carcinogens in mammalian cells. I. The use of selectable gene loci. Ann Ist Super Sanita 30: 183-190, 1994.
8. 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis. IARC Sci Publ pp189-205, 1989.
9. Perera FP: Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst 78: 887-898, 1987.
10. IARC Monograph on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 32, Polynuclear aromatic compounds. Part 1, Chemical, environmental and experimental data. IARC Press, Lyon, 1983.
11. IARC Monograph on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 33, Polynuclear aromatic compounds. Part 2, Carbons blacks, mineral oils, and some nitroarenes. IARC Press, Lyon, 1984.
12. Widlak P and Rzeszowska Wolny J: DNA and proteins of the nuclear matrix are the main targets of benzo[a]pyrene's action in rat hepatocytes. Acta Biochim Pol 40: 559-562, 1993.
13. DiGiovanni J, Beltran L, Rupp A, Harvey RG and Gill RD: Further analysis of c-Ha-ras mutations in papillomas initiated by several polycyclic aromatic hydrocarbons and papillomas from uninitiated, promoter-treated skin in SENCAR mice. Mol Carcinog 8: 272-279, 1993.
14. Iannaccone PM, Fahl WE and Stols L: Reproductive toxicity associated with endometrial cell mediated metabolism of benzo[a]pyrene: a combined in vitro, in vivo approach. Carcinogenesis 5: 1437-1442, 1984.
15. Pairon JC, Trabelsi N, Buard A, Fleury Feith J, Bachelet CM, Poron F, Beaune P, Brochard P and Laurent P: Cell localization and regulation of expression of cytochrome P450 1A1 and 2B1 in rat lung after induction with 3-methylcholanthrene using mRNA hybridization and immunohistochemistry. Am J Respir Cell Mol Biol 11: 386-396, 1994.
16. Burke MD, Thompson S, Weaver RJ, Wolf CR and Mayer RT: Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48: 923-936, 1994.
17. Weaver RJ, Dunbar B, Dickins M, Melvin WT, Fothergill J and Burke MD: Evidence for a new cytochrome P450 form induced by 3-methylcholanthrene in rats. Biochem Pharmacol 47: 1457-1460, 1994.
18. Sizemore N, Mukhtar H, Couch LH, Howard PC and Rorke EA: Differential response of normal and HPV immortalized ectocervical epithelial cells to B[a]P. Carcinogenesis 16: 2413-2418, 1995.
19. Mazur M and Glickman BW: Sequence specificity of mutations induced by benzo[a]pyrene-7,8- diol-9,10-epoxide at endogenous arpt gene in CHO cells. Somat Cell Mol Genet 14: 393-400, 1988.
20. Santella RM, Weston A, Perera FP, Trivers GT, Harris CC, Young TL, Nguyen D, Lee BM and Poirier MC: Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. Carcinogenesis 9: 1265-1269, 1988.
21. Reed GA and Jones BC: Enhancement of benzo[a]pyrene diol epoxide mutagenicity by sulfite in a mammalian test system. Carcinogenesis 17: 1063-1068, 1996.
22. Bjelogrlic NM, Makinen M, Stenback F and Vahakangas K: Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis 15: 771-774, 1994.
23. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
24. Canman CE, Chen CY, Lee MH and Kastan MB: DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis. Cold Spring Harb Symp Quant Biol 59: 277-286, 1994.
25. Lane DP: P53, guardian of the genome. Nature 358: 15-16, 1992.
26. Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB and Cho KR: p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavims 16 E7 oncoprotein. Proc Natl Acad Sci USA 91: 5320-5324, 1994.
27. Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr, Vogelstein B and Kastan MB: Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 91: 2684-2688, 1994.
28. Kastan MB: P53: a determinant of the cell cycle response to DNA damage. Adv Exp Med Biol 339: 291-293, 1993.
29. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L and Cho KR: Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90: 3988-3992, 1993.
30. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 17 promotes the degradation of p53. Cell 63: 1129-1136, 1990.
31. Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hendrick L, Kastan MB, Cho KR: p53 G1 arrest involves pRB related proteins and is disrupted by human papillomavirus 16 E7 protein. Proc Natl Acad Sci USA 91: 5320-5324, 1994.
32. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ and Vousden KH: Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 339: 1070-1073, 1992.
33. Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF and Chang EH: The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines. Carcinogenesis 13: 1273-1275, 1992.
34. Gorodeski GI, Eckert RL, Utian WH, Sheean L and Rorke EA: Cultured human ectocervical epithelial cell differentiation is regulated by the combined direct actions of sex steroids, glucocorticoids, and retinoids. J Clin Endocrinol Metab 70: 1624-1630, 1990.
35. Gorodeski GI, Eckert RL, Utian WH and Rorke EA: Maintenance of in vivo-like keratin expression, sex steroid responsiveness, and estrogen receptor expression in cultured human ectocervical epithelial cells. Endocrinology 126: 399-406, 1990.
36. Sizemore N and Rorke EA: Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res 53: 4511-4517, 1993.
37. Kasturi L, Sizemore N, Eckert RL, Martin K and Rorke EA: Calcium modulates cornified envelope formation, involucrin content, and transglutaminase activity in cultured human ectocervical epithelial cells. Exp Cell Res 205: 84-90, 1993.
38. Gorodeski GI, Eckert RL, Utian WH, Sheean L and Rorke EA: Retinoids, sex steroids and glucocorticoids regulate ectocervical cell envelope formation but not the level of the envelope precursor, involucrin. Differentiation 42: 75-80, 1989.
39. Sizemore N, Kasturi L, Gorodeski G, Eckert RL, Jetten AM and Rorke EA: Retinoid regulation of human ectocervical epithelial cell transglutaminase activity and keratin gene expression. Differentiation 54: 219-225, 1993.
40. Rice RH and Green H: Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18: 681-694, 1979.
41. DeMarco GJ and McCoy GD: Involvement of cytochrome b5 in the hepatic microsomal metabolism of benzo(a)pyrene. Biochem Biophys Res Commun 128: 621-627, 1985.
42. 32P-postlabelling analysis of aromatic carcinogens: DNA adducts. Cancer Res 45: 5656-5662, 1985.
43. 32P adduct assay: comparative recoveries of structurally diverse DAN adducts in the various enhancement procedures. Carcinogenesis 9: 1687-1693, 1988.
44. 32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermas of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis 6: 1117-1126, 1985.
45. Greenberg CS, Birckbichler PJ and Rice RH: Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5: 3071-3077, 1991.
46. Kimmig R, Kapsner T, Spelsberg H, Untch M and Hepp H: DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labeling for identification of tumour cells. J Cancer Res Clin Oncol 121: 107-114, 1995.
47. Van Bommel PF, Kenemans P, Helmerhorst TJ, Gallee MP and Ivanyi D: Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix. Cancer 74: 2314-2320, 1994.
48. Inman GJ, Cook ID and Lau RK: Human papillomaviruses, tumour suppressor genes and cervical cancer. Int J STD AIDS 4: 128-134, 1993.
49. Turek LP and Smith EM: The genetic program of human papillomavirus in infection and cancer. Obstet Gynecol Clin North Am 23: 735-758, 1996.
50. Shiraswa H, Tomita Y, Sekiya S, Takamizawa H and Simizu B: Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 68: 583-591, 1987.
51. Dyson N, Howley PM, Munger K and Harlow E: The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 243: 934-937, 1989.
52. DiPaolo JA, Woodworth CD, Popescu NC, Notario V and Doniger J: Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 4: 395-399, 1989.
53. Kastan MB, Canman CE and Leonard CJ: P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14: 3-15, 1995.
54. Rubin AL and Rice RH: Modulation of 3-methycholanthrene toxicity in cultured neoplastic keratinocytes by glucocorticoids and retinoids is not accounted for by macromolecular adduct formation. Proc Natl Acad Sci USA 86: 2961-2965, 1989.
55. Eckert RL and Rorke EA: Molecular biology of keratinocyte differentiation. Environ Health Perspect 80: 109-116, 1989.
56. Stockwell HG and Lyman GH: Cigarette smoking and the risk of female reproductive cancer. Am J Obstet Gynecol 157: 35-40, 1987.
57. Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, Gaitan E, Garcia M and Rawls WE: Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 81: 205-211, 1989.
58. Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD, Kurman RJ, Brinton LA, Lannom LB and Hoffmann D: Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res 47: 3886-3888, 1987.
59. Sasson IM, Haley NJ, Hoffmann D, Wynder EL, Hellberg D and Nilsson S: Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med 312: 315-316, 1985.
60. Phillips DH and She MN: DNA adducts in cervical tissue of smokers and non-smokers. Mutat Res 313: 277-284, 1994.
61. Simons AM, Phillips DH and Coleman DV: DNA adduct assay in cervical epithelium. Diagn Cytopathol 10: 284-288, 1994.